NDC 70700-269

Deferasirox

Deferasirox

Deferasirox is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Xiromed, Llc. The primary component is Deferasirox.

Product ID70700-269_0d29e8ec-b53b-46f5-9ca1-71c6ad1c40bf
NDC70700-269
Product TypeHuman Prescription Drug
Proprietary NameDeferasirox
Generic NameDeferasirox
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-01-02
Marketing CategoryANDA / ANDA
Application NumberANDA212995
Labeler NameXiromed, LLC
Substance NameDEFERASIROX
Active Ingredient Strength90 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70700-269-30

30 TABLET in 1 BOTTLE, PLASTIC (70700-269-30)
Marketing Start Date2020-01-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70700-269-30 [70700026930]

Deferasirox TABLET
Marketing CategoryANDA
Application NumberANDA212995
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-01-02

Drug Details

Active Ingredients

IngredientStrength
DEFERASIROX90 mg/1

OpenFDA Data

SPL SET ID:4c36bb5a-2552-46c1-8500-4ae783cffef1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1607792
  • 1607796
  • UPC Code
  • 0370700269305
  • 0370700271308
  • Pharmacological Class

    • Iron Chelating Activity [MoA]
    • Iron Chelator [EPC]
    • Cytochrome P450 3A4 Inducers [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • Cytochrome P450 1A2 Inhibitors [MoA]

    NDC Crossover Matching brand name "Deferasirox" or generic name "Deferasirox"

    NDCBrand NameGeneric Name
    45963-454DeferasiroxDeferasirox
    45963-456DeferasiroxDeferasirox
    45963-455DeferasiroxDeferasirox
    46708-326DeferasiroxDeferasirox
    46708-410DEFERASIROXDEFERASIROX
    46708-325DeferasiroxDeferasirox
    46708-324DeferasiroxDeferasirox
    46708-412DEFERASIROXDEFERASIROX
    62332-326DeferasiroxDeferasirox
    62332-324DeferasiroxDeferasirox
    62332-325DeferasiroxDeferasirox
    62332-410DEFERASIROXDEFERASIROX
    62332-412DEFERASIROXDEFERASIROX
    67877-551DeferasiroxDeferasirox
    67877-550DeferasiroxDeferasirox
    67877-549DeferasiroxDeferasirox
    69539-023DeferasiroxDeferasirox
    69539-073DeferasiroxDeferasirox
    69539-022DeferasiroxDeferasirox
    69539-075DeferasiroxDeferasirox
    69539-021DeferasiroxDeferasirox
    70710-1277deferasiroxdeferasirox
    70710-1275deferasiroxdeferasirox
    43598-851DeferasiroxDeferasirox
    43598-855DeferasiroxDeferasirox
    43598-856DeferasiroxDeferasirox
    43598-853DeferasiroxDeferasirox
    43598-854DeferasiroxDeferasirox
    62756-569deferasiroxdeferasirox
    62756-570deferasiroxdeferasirox
    62756-568deferasiroxdeferasirox
    69452-159DeferasiroxDeferasirox
    69452-161DeferasiroxDeferasirox
    69452-160DeferasiroxDeferasirox
    70771-1471deferasiroxdeferasirox
    70771-1473deferasiroxdeferasirox
    0093-3515DeferasiroxDeferasirox
    0093-3517DeferasiroxDeferasirox
    0591-3853DeferasiroxDeferasirox
    16714-995deferasiroxdeferasirox
    16714-993deferasiroxdeferasirox
    0078-0468Exjadedeferasirox
    0078-0469Exjadedeferasirox
    0078-0470Exjadedeferasirox
    0078-0654Jadenudeferasirox
    0078-0655Jadenudeferasirox
    0078-0656Jadenudeferasirox

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.